Cas:121492-10-2 tert-butyl N-(2-hydroxyethyl)-N-phenylcarbamate manufacturer & supplier

We serve Chemical Name:tert-butyl N-(2-hydroxyethyl)-N-phenylcarbamate CAS:121492-10-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-butyl N-(2-hydroxyethyl)-N-phenylcarbamate

Chemical Name:tert-butyl N-(2-hydroxyethyl)-N-phenylcarbamate
CAS.NO:121492-10-2
Synonyms:N-tert-butoxycarbonyl-N-phenylaminoethanol;2-Methyl-2-propanyl (2-hydroxyethyl)phenylcarbamate;tert-Butyl (2-hydroxyethyl)phenylcarbamate;N-phenyl-N-(tert-butoxtcarbonyl)-2-aminoethanol;N-tert-butoxycarbonyl-N-(2-hydroxyethyl)aniline;tert-butyl (2-hydroxyethyl)(phenyl)carbamate;(2-hydroxy-ethyl)-phenyl-carbamic acid tert-butyl ester;Carbamic acid, N-(2-hydroxyethyl)-N-phenyl-, 1,1-dimethylethyl ester;Carbamic acid,(2-hydroxyethyl)phenyl-,1,1-dimethylethyl ester (9CI)
Molecular Formula:C13H19NO3
Molecular Weight:237.295
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:345.1±25.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.548
PSA:49.77000
Exact Mass:237.136490
LogP:2.69

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-tert-butoxycarbonyl-N-phenylaminoethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Carbamic acid,(2-hydroxyethyl)phenyl-,1,1-dimethylethyl ester (9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl (2-hydroxyethyl)(phenyl)carbamate Use and application,N-tert-butoxycarbonyl-N-phenylaminoethanol technical grade,usp/ep/jp grade.


Related News: We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.” bismuth,potassium manufacturers But when it came to deciding on whether Americans with compromised immune systems should get an extra dose of any COVID-19 vaccine, the CDC said it would need to wait for the FDA to give its regulatory thumbs up first. That could come either through amending its emergency use nods or awarding full approvals. 2-(2,3-dichloro-benzenesulfonylamino)-6,7-dihydro-4H-thiazolo [5,4-c]pyridine-5-carboxylic acid ter-butyl ester suppliers The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). ruthenium,zinc vendor & factory.